Lenoss Medical is a growth-stage biomedical company headquartered in Providence, RI, focused on biological solutions for physiological repair of skeletal defects. Its flagship platform, OsteoPearl®, is an implant and surgical instrument system designed to enable physicians to place natural bone where additional bone is required in spinal vertebral augmentation procedures. The company reported record sales in the fourth quarter and year-over-year surgical procedure growth of nearly 150%, demonstrating accelerating clinical adoption. Management plans to use new capital to expand commercial coverage by hiring regional sales leadership, to increase clinical data generation, and to scale operations and marketing to support further adoption. The company is led by an experienced team of MedTech professionals and counts multiple venture investors and angels among its backers.

Total raised

$10M

Funding rounds

2

Latest round

Equity

Latest activity

Mar 2026